Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer-Reference-Cited by-同舟云学术

Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer

Published:2016-12-08 Issue:3 Volume:62 Page:379-387
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Antonucci Ivana,Provenzano Martina,Sorino Luca,Balsamo Michela,Aceto Gitana Maria,Battista Pasquale,Euhus David,Cianchetti Ettore,Ballerini Patrizia,Natoli Clara,Palka Giandomenico,Stuppia Liborio

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

https://www.nature.com/articles/jhg2016138.pdf

Reference46 articles.

1. Karami, F. & Mehdipour, P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res. Int. 2013, 928562 (2013).

2. Kwon, J. S., Gutierrez-Barrera, A. M., Young, D., Sun, C. C., Daniels, M. S., Lu, K. H. et al. Expanding the criteria for BRCA mutation testing in breast cancer survivors. J. Clin. Oncol. 28, 4214–4220 (2012).

3. Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B. et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J. Clin. Oncol. 20, 1480–1490 (2002).

4. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130 (2003).

5. Nelson, H. D., Huffman, L. H., Fu, R. & Harris, E. L. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 143, 362–379 (2005).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects;Cancers;2024-06-25

2. Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2;Cancers;2023-12-06

3. Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis;Frontiers in Genetics;2023-02-01